{"log_id": 6986687333312502167, "direction": 0, "words_result_num": 46, "words_result": [{"probability": {"variance": 2e-06, "average": 0.998675, "min": 0.994516}, "location": {"width": 267, "top": 186, "height": 36, "left": 119}, "words": "2、在开启前无特殊注意事项"}, {"probability": {"variance": 0.007647, "average": 0.981552, "min": 0.405779}, "location": {"width": 1025, "top": 198, "height": 57, "left": 155}, "words": "每支安瓿只能供一名患者一次使用。在安瓿瓶启封后应立即使用,未经使用的溶液应弃去。有研究证国家食"}, {"probability": {"variance": 8e-06, "average": 0.998721, "min": 0.986247}, "location": {"width": 617, "top": 240, "height": 45, "left": 119}, "words": "明,启封后在室温下存放24小时,溶液的物理和化学特性是稳定的"}, {"probability": {"variance": 0, "average": 0.99996, "min": 0.999941}, "location": {"width": 56, "top": 251, "height": 28, "left": 1114}, "words": "药品"}, {"probability": {"variance": 1.4e-05, "average": 0.997955, "min": 0.976527}, "location": {"width": 902, "top": 263, "height": 54, "left": 156}, "words": "从微生物学的角度看,药液应在开启后立即使用。如果不能马上使用,在2~8℃条件下存放的时间不"}, {"probability": {"variance": 1e-06, "average": 0.999218, "min": 0.993602}, "location": {"width": 817, "top": 300, "height": 47, "left": 117}, "words": "宜超过24小时,除非所有配置、稀释等过程完全是在经控制的和验证过的无菌条件下完成"}, {"probability": {"variance": 0, "average": 0.999814, "min": 0.999814}, "location": {"width": 30, "top": 292, "height": 29, "left": 1128}, "words": "附"}, {"probability": {"variance": 5e-06, "average": 0.999013, "min": 0.986082}, "location": {"width": 895, "top": 329, "height": 51, "left": 155}, "words": "盐酸羟考酮注射液与下列物质兼容:丁基东莨菪碱、氢溴酸东莨菪碱、地塞米松磷酸钠、氟哌啶醇"}, {"probability": {"variance": 1e-05, "average": 0.997854, "min": 0.985428}, "location": {"width": 434, "top": 372, "height": 40, "left": 119}, "words": "盐酸咪唑安定、盐酸甲氧氯普胺、盐酸左美丙嗪"}, {"probability": {"variance": 0.004828, "average": 0.986506, "min": 0.502869}, "location": {"width": 905, "top": 392, "height": 50, "left": 158}, "words": "未经稀释的及以0.9%wlv生理盐水或5%葡萄糖或水稀释至1mg/ml浓度的盐酸羟考酮注射液,与质量"}, {"probability": {"variance": 0.000736, "average": 0.989981, "min": 0.859719}, "location": {"width": 942, "top": 423, "height": 51, "left": 120}, "words": "可靠的聚乙烯或聚碳酸酯注射器,PVC管、PVC或EVA输液袋接触,在室温条件下,于24小时内,在物"}, {"probability": {"variance": 1e-06, "average": 0.999067, "min": 0.997363}, "location": {"width": 209, "top": 471, "height": 34, "left": 120}, "words": "理和化学方面是稳定的"}, {"probability": {"variance": 4.8e-05, "average": 0.997763, "min": 0.954763}, "location": {"width": 903, "top": 487, "height": 47, "left": 160}, "words": "研究表明,放在各种容器中的,不论是未经稀释的注射液或是已稀释至1mg/ml的输注液,均无需避"}, {"probability": {"variance": 0, "average": 0.999716, "min": 0.999716}, "location": {"width": 25, "top": 541, "height": 24, "left": 121}, "words": "光"}, {"probability": {"variance": 4.4e-05, "average": 0.997585, "min": 0.964228}, "location": {"width": 559, "top": 555, "height": 41, "left": 161}, "words": "安瓿启封后,不适当地操作未经稀释的注射液存在染菌的危险"}, {"probability": {"variance": 3.3e-05, "average": 0.997897, "min": 0.969411}, "location": {"width": 792, "top": 580, "height": 49, "left": 124}, "words": "3、本品不可与除上文(注意事项部分第12条)提及药物以外的其他医药产品混合使用"}, {"probability": {"variance": 3.1e-05, "average": 0.997635, "min": 0.966266}, "location": {"width": 898, "top": 610, "height": 49, "left": 161}, "words": "当苯甲嗪的浓度在3mg/ml或更低时,不论与未经稀释的盐酸羟考酮注射液或是经水稀释过的盐酸羟"}, {"probability": {"variance": 4e-05, "average": 0.997251, "min": 0.963691}, "location": {"width": 939, "top": 642, "height": 49, "left": 123}, "words": "考酮注射液混合,室温存放24小时,没有发生沉淀的迹象。当盐酸羟考酮注射液与浓度大于3mg/ml或经"}, {"probability": {"variance": 1.4e-05, "average": 0.998892, "min": 0.975483}, "location": {"width": 944, "top": 673, "height": 50, "left": 122}, "words": "生理盐水稀释的苯甲嗪溶液混合后会发生沉淀。当同时静脉注射或皮下输注苯甲嗪和盐酸羟考酮时,应加"}, {"probability": {"variance": 1e-06, "average": 0.998462, "min": 0.997659}, "location": {"width": 63, "top": 727, "height": 24, "left": 123}, "words": "水稀释"}, {"probability": {"variance": 4e-06, "average": 0.998783, "min": 0.991061}, "location": {"width": 436, "top": 746, "height": 39, "left": 163}, "words": "氯吡嗪与盐酸羟考酮注射液在化学上是不相容的"}, {"probability": {"variance": 0.000353, "average": 0.995504, "min": 0.88103}, "location": {"width": 772, "top": 771, "height": 45, "left": 124}, "words": "14、根据《反兴奋剂条例》,羟考酮为兴奋剂目录所列禁用物质,因此运动员慎用本品"}, {"probability": {"variance": 4e-06, "average": 0.998905, "min": 0.992792}, "location": {"width": 237, "top": 844, "height": 32, "left": 130}, "words": "【孕妇及哺乳期妇女用药】"}, {"probability": {"variance": 0.00445, "average": 0.988552, "min": 0.556345}, "location": {"width": 902, "top": 858, "height": 50, "left": 164}, "words": "尚无充分的研究来了解羟考酮对人类生殖的影响也没有研究过在怀孕期间曾暴露于药物对生产及产"}, {"probability": {"variance": 0.001322, "average": 0.988951, "min": 0.831402}, "location": {"width": 410, "top": 903, "height": 36, "left": 125}, "words": "后所造成的影响。然而,大鼠和兔子分别口服"}, {"probability": {"variance": 0.012345, "average": 0.971177, "min": 0.487283}, "location": {"width": 354, "top": 893, "height": 31, "left": 694}, "words": "倍成人给药剂量(160mg/日)的羟考酮"}, {"probability": {"variance": 0.000145, "average": 0.993963, "min": 0.959772}, "location": {"width": 389, "top": 932, "height": 41, "left": 123}, "words": "均没有发现对胎仔的毒性。不推荐将盐酸"}, {"probability": {"variance": 0.002306, "average": 0.986364, "min": 0.789122}, "location": {"width": 370, "top": 922, "height": 35, "left": 698}, "words": "极分娩中。如果孕妇怀孕期间曾使用过阿"}, {"probability": {"variance": 0, "average": 0.999477, "min": 0.998127}, "location": {"width": 373, "top": 965, "height": 38, "left": 125}, "words": "片类药物,婴儿出生后需监测呼吸抑制情"}, {"probability": {"variance": 0.013223, "average": 0.952117, "min": 0.51651}, "location": {"width": 905, "top": 987, "height": 50, "left": 165}, "words": "羟考酮可通过乳汁排出,所以可能会生婴业呼因此,哺乳妇女不应使用盐酸羟考酮"}, {"probability": {"variance": 2e-06, "average": 0.998654, "min": 0.996951}, "location": {"width": 63, "top": 1038, "height": 24, "left": 127}, "words": "注射液"}, {"probability": {"variance": 0, "average": 0.970357, "min": 0.970357}, "location": {"width": 40, "top": 1035, "height": 38, "left": 648}, "words": "A"}, {"probability": {"variance": 0.002891, "average": 0.981172, "min": 0.738674}, "location": {"width": 580, "top": 1084, "height": 43, "left": 133}, "words": "【儿童用药】尚没有18岁以下儿童使用盐酸羟考酮注射沁数据"}, {"probability": {"variance": 1.3e-05, "average": 0.998313, "min": 0.982941}, "location": {"width": 552, "top": 1148, "height": 39, "left": 132}, "words": "【老年用药】治疗时需慎重。应小心从最低起始剂量开始滴定"}, {"probability": {"variance": 7e-06, "average": 0.99829, "min": 0.991457}, "location": {"width": 156, "top": 1217, "height": 31, "left": 132}, "words": "【药物相互作用】"}, {"probability": {"variance": 1e-06, "average": 0.999328, "min": 0.994299}, "location": {"width": 884, "top": 1234, "height": 45, "left": 168}, "words": "羟考酮能增强以下药物的中枢镇静作用,这些药物包括镇定剂、麻醉剂、安眠药、抗抑郁药、镇静剂"}, {"probability": {"variance": 0.00012, "average": 0.997163, "min": 0.925262}, "location": {"width": 943, "top": 1264, "height": 47, "left": 128}, "words": "吩噻嗪、安定类药物、酒精、其它阿片类药物、肌松剂和降压药。已知单胺氧化酶抑制剂能与麻醉性镇痛"}, {"probability": {"variance": 4e-06, "average": 0.998774, "min": 0.991508}, "location": {"width": 741, "top": 1298, "height": 44, "left": 128}, "words": "药相互作用,引起伴有高血压危象或低血压危象的中枢神经系统的兴奋或抑制作用"}, {"probability": {"variance": 0.000126, "average": 0.995705, "min": 0.937072}, "location": {"width": 900, "top": 1326, "height": 45, "left": 169}, "words": "羟考酮部分通过CYP2D6和CYP3A4途径代谢。这些途径可以被多种药物阻断,但这些药物的阻滞作"}, {"probability": {"variance": 1.1e-05, "average": 0.998166, "min": 0.989141}, "location": {"width": 189, "top": 1375, "height": 26, "left": 128}, "words": "用尚未显示临床意义"}, {"probability": {"variance": 2e-06, "average": 0.998429, "min": 0.995873}, "location": {"width": 110, "top": 1435, "height": 25, "left": 138}, "words": "【药物过量】"}, {"probability": {"variance": 2e-06, "average": 0.998737, "min": 0.995415}, "location": {"width": 146, "top": 1466, "height": 26, "left": 134}, "words": "用药过量的症状"}, {"probability": {"variance": 3e-06, "average": 0.999183, "min": 0.991989}, "location": {"width": 903, "top": 1479, "height": 46, "left": 171}, "words": "羟考酮中毒和药物过量的体征为:针尖样瞳孔、呼吸抑制、低血压和幻觉。恶心和呕吐症状通常出现"}, {"probability": {"variance": 3.3e-05, "average": 0.998415, "min": 0.96084}, "location": {"width": 943, "top": 1510, "height": 47, "left": 131}, "words": "在少数严重病例中,非心源性肺水肿和横纹肌溶解常见于静脉注射阿片类镇痛药后。某些更严重的病例可"}, {"probability": {"variance": 1.5e-05, "average": 0.998279, "min": 0.97981}, "location": {"width": 761, "top": 1545, "height": 43, "left": 133}, "words": "能出现循化衰竭和嗜睡乃至昏迷或深度昏迷、骨骼肌无力、心动过缓,乃至发生死亡"}, {"probability": {"variance": 4e-06, "average": 0.999095, "min": 0.991737}, "location": {"width": 476, "top": 1580, "height": 37, "left": 172}, "words": "同时使用酒精或其他精神药物会加大药物过量的影响"}], "language": 3}